Dr. Murashige is a senior partner at Morrison & Foerster and former co-chair of the firm’s Patent Group. Her practice focuses on the pharmaceutical and healthcare industries. She is a member of the AAAS committee on Scientific Freedom and Responsibility. Dr. Murashige was selected as a top attorney by her peers in The Best Lawyers in America 2007-2009® in the field of biotechnology law. In 2006, she received the Distinguished Alumna Award from Washington University in St. Louis for attaining distinction in her professional career and for having demonstrated service to the community and the university.

Dr. Murashige has practiced law since 1977. She was associated with the firm of Lyon & Lyon of Los Angeles and was in corporate practice at Syntex and later at Genentech. In 1983, she left Genentech to form Ciotti & Murashige, which became one of the nation’s premier biotechnology and bioscience practices. She joined Morrison & Foerster in 1991 along with the rest of the Ciotti & Murashige group.

Dr. Murashige has taught college chemistry and was Physical Sciences Chairperson of the College of San Mateo for six years. She was formerly President of the Peninsula Intellectual Property Law Association, and a member of the United States Patent and Trademark Office Biotechnology Institute Board. Dr. Murashige was a member of the former National Biotechnology Policy Board for NIH, and is a past chairperson of the Biotechnology Committee of the American Intellectual Property Law Association. She was chosen as one of the Best Lawyers in Washington by her peers.

Dr. Murashige received her BA from Washington University in St. Louis in 1956, her Ph.D. from UCLA in 1962, and her JD, summa cum laude from Santa Clara University School of Law in 1977.

Dr. Murashige’s representative matters include:

• QLT, Inc. - Representation of QLT, Inc. in connection with its patent transactions.
• NuVant Systems, Inc. - Representation of NuVant Systems, Inc. in the preparation and prosecution of company's patents.
• Scios, Inc. - Representation of Scios, Inc. in connection with its patent transactions.
• Washington University, St. Louis - Representation of Washington University in connection with its patent transactions.
• Osteoscreen - Representation of Osteoscreen in connection with its patent transactions.
• Pentech Pharmaceuticals - Representation of Agensys in connection with its patent transactions.
• Genzyme, Inc. - Representation of AnorMED Inc. in connection with its patent transactions.
• Sanderling Biomedical Venture - Representation of Sanderling in due diligence matters.
• HIG - Representation of HIG in due diligence matters.
• Stanford University - Representation of Stanford University in connection with its patent transactions.
• University of California - Representation of the University of California in connection with its patent transactions.
• Kosan Biosciences, Inc. - Representation of Kosan in connection with its patent transactions.
• Neuromed Pharmaceuticals - Representation of Neuromed Pharmaceuticals in connection with its patent transactions.
• Celator - Representation of Celator in connection with its patent transactions.
• VIRxSYS Corporation - Representation of VIRxSYS Corporation in connection with its patent transactions.
• ABR, LLC - Representation of ABR, LLC in connection with its patent transactions.
• Agensys Inc. - Representation of Agensys in drafting and obtaining approvals for its applications for patents relating to cancer treatment technology.
• Anti Cancer - Representation of Anti Cancer in connection with its patent transactions.
• Hawaii Biotechnology Group, Inc. - Representation of Hawaii Biotechnology Group, Inc. in connection with its patent transactions.
• Trellis Biosciences, Inc. - Trellis Biosciences, Inc. in connection with general corporate and other transactional matters and intellectual property counseling, including the preparation and prosecution of the company's patents.
• Neugenesis Corp. - Representation of Neugenesis in connection with its patent transactions.
• DSM - Representation of DSM in connection with its patent transactions.
• Kereos, Inc. - Representation of Kereos in connection with its patent transactions.